New approaches for the design of HIV-1 protease inhibitors

In general, enzyme inhibitors used as therapeutic agents are organic molecules that interact mainly with the proteins through hydrogen bonding and van der Waals contacts. Metal-organic complexes hold the attractive promise of forming stronger attachments with the target by combining the coordination ability of metals with the stereoelectronic properties of the ligand.